ERCC 1/BRCA1 PROTEIN EXPRESSIONS AND ERCC1/XPD/XRCC1-3 GENE POLYMORPHISMS AS PREDICTOR FACTORS OF OUTCOME IN STAGE IIIB-IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED IN FIRST-LINE CHEMOTHERAPY WITH OR WITHOUT CISPLATIN